Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Molecular Cell
|
November 14, 2020
Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA
Shuai Yuan, Lei Peng, Jonathan J Park, et al.
Nature Biotechnology
|
September 25, 2019
In vivo CRISPR screening in CD8 T cells with AAV-Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma
Lupeng Ye, Jonathan J Park, Matthew B Dong, et al.
Cell Reports
|
August 3, 2022
Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species
Lei Peng, Zhenhao Fang, Paul A Renauer, et al.
Nature Immunology
|
July 27, 2023
CTLA-4 tail fusion enhances CAR-T antitumor immunity
Xiaoyu Zhou, Hanbing Cao, Shao-Yu Fang, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
CTLA-4 tail fusion enhances CAR-T anti-tumor immunity
Xiaoyu Zhou, Hanbing Cao, Shao-Yu Fang, et al.
Cell Reports. Medicine
|
May 13, 2022
Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2
Lei Peng, Paul A Renauer, Arya Ökten, et al.
Nature Immunology
|
October 16, 2019
Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity
Guangchuan Wang, Ryan D Chow, Zhigang Bai, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
Cas12a/Cpf1 knock-in mice enable efficient multiplexed immune cell engineering
Matthew B Dong, Kaiyuan Tang, Xiaoyu Zhou, et al.
Cancer Discovery
|
September 5, 2020
CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade
Guangchuan Wang, Ryan D Chow, Lvyun Zhu, et al.
Nature Neuroscience
|
August 15, 2017
AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma
Ryan D Chow, Christopher D Guzman, Guangchuan Wang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Molecular Cell
|
November 14, 2020
Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA
Shuai Yuan, Lei Peng, Jonathan J Park, et al.
Nature Biotechnology
|
September 25, 2019
In vivo CRISPR screening in CD8 T cells with AAV-Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma
Lupeng Ye, Jonathan J Park, Matthew B Dong, et al.
Cell Reports
|
August 3, 2022
Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species
Lei Peng, Zhenhao Fang, Paul A Renauer, et al.
Nature Immunology
|
July 27, 2023
CTLA-4 tail fusion enhances CAR-T antitumor immunity
Xiaoyu Zhou, Hanbing Cao, Shao-Yu Fang, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
CTLA-4 tail fusion enhances CAR-T anti-tumor immunity
Xiaoyu Zhou, Hanbing Cao, Shao-Yu Fang, et al.
Cell Reports. Medicine
|
May 13, 2022
Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2
Lei Peng, Paul A Renauer, Arya Ökten, et al.
Nature Immunology
|
October 16, 2019
Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity
Guangchuan Wang, Ryan D Chow, Zhigang Bai, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
Cas12a/Cpf1 knock-in mice enable efficient multiplexed immune cell engineering
Matthew B Dong, Kaiyuan Tang, Xiaoyu Zhou, et al.
Cancer Discovery
|
September 5, 2020
CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade
Guangchuan Wang, Ryan D Chow, Lvyun Zhu, et al.
Nature Neuroscience
|
August 15, 2017
AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma
Ryan D Chow, Christopher D Guzman, Guangchuan Wang, et al.
Page
of 3